Crowdsourced Genomic Resource DNA.Land to Relaunch as Company

Sep 16, 2019

|

NEW YORK – DNA.Land, a resource launched four years ago by researchers at Columbia University and the New York Genome Center that crowdsources genomic data from consumer genomics customers for research purposes, said this week that it would be shutting down and relaunching as a company.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Breaking News

The Scan

This Time, Novavax

Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.

Shortened Visas for Some Students

Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.

New York's Own Review

The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.

Featured White Papers

Novel Artificial Intelligence (AI)-based Technology to Improve Oncology Clinical Trial Fulfillment

Compatibility of liquid biopsy assays on multiple sequencing platforms

A Pharma’s Guide to Working with UK Biobank Data

From Synthetic Gene to Vaccine: Confidence with GeneArt Gene Synthesis Services A GenomeWeb eCase Study Transcript

Sep

30

Featured Webinar

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care.

Oct

01

Featured Webinar

Immune Repertoire Sequencing to Uncover SARS-CoV-2-Specific T Cell Responses and Dynamics

T cells are the adaptive immune system’s first responders to any virus, circulating in the blood to detect and quickly multiply to attack the virus, and also support the development of antibodies by B cells.

Oct

08

Featured Webinar

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

This webinar, Part 3 of the “Advances in RNA-based Biomarker Development for Precision Oncology” webinar series sponsored by GeneCentric Therapeutics, will discuss novel and emerging applications of RNA-based genomic analysis in precision oncology, form characterizing the tumor microenvironment to informing the development of immuno-oncology treatments.

Oct

21

Featured Webinar

Target Enrichment NGS Panel Outperforms the Gold Standard for Sequence and CNV Analysis

Target enrichment has been a major driver behind the clinical adoption of next-generation sequencing (NGS) over the last decade because it simplifies analysis and provides a cost-effective method of massive parallel resequencing. It has not only replaced Sanger sequencing, but it is actively dispensing the need for parallel copy number variant (CNV) analysis using classic techniques.

Menu

Crowdsourced Genomic Resource DNA.Land to Relaunch as Company

To read the full story....

Breaking News

M2Gen Expands Partnership With Discovery Life Sciences

Mutations in Type I Interferon Immunity Genes Underlie Severe COVID-19

Palmetto Expands Coverage for Decipher Biosciences Prostate Cancer Test

Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

In Brief This Week: Fluidigm, Thermo Fisher Scientific, Veracyte, and More

The Scan

This Time, Novavax

Shortened Visas for Some Students

New York's Own Review

Science Papers Examine Y Chromosomes of Archaic Humans, Schistosomiasis Therapeutic Targets

Featured White Papers

Moving from Non-Invasive Prenatal Screening to Prenatal Diagnostics: An Expert Panel Discussion

Immune Repertoire Sequencing to Uncover SARS-CoV-2-Specific T Cell Responses and Dynamics

Novel Applications of RNA-based Precision Oncology: From Drug Tolerability to Immunogenomics

Target Enrichment NGS Panel Outperforms the Gold Standard for Sequence and CNV Analysis

What's Popular?

Catalog DNA Merges Molecular Biology, Information Theory to Pursue DNA-Based Computing

Clear Labs Nanopore Sequencing Coronavirus Test Gets FDA Emergency Use Authorization

M2Gen Expands Partnership With Discovery Life Sciences

Google DeepVariant Boosts Accuracy of Indel Calls in PacBio Long Reads

Sponsorships